Sai Life Sciences lists with 20% premium on the BSE
Sai Life Sciences has debuted at Rs 660.00 on the BSE, up by 111 points or 20.22% from its issue price of Rs 549.00.
The scrip is currently trading at Rs 705.85, up by 156.85 points or 28.57% from its issue price.
It has touched a high and low of Rs 724.00 and Rs 651.20 respectively. So far 21.95 lakh shares were traded on the counter.
The offering, which was open for subscription between December 11, 2024 and December 13, 2024 was subscribed over 30.90 times. The issue price was fixed at Rs 549.00 per share i.e. at upper end of price band of Rs 522-549 apiece.
Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
